Decker Robert J 4
4 · JOHNSON & JOHNSON · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
Johnson & Johnson (JNJ) VP Robert Decker Exercises Options and Sells Shares
What Happened
- Robert J. Decker, Vice President & Corporate Controller at Johnson & Johnson, exercised 4,075 stock options at an exercise price of $115.67 per share (cost ≈ $471,355) on Feb 27, 2026. He then sold the 4,075 shares in an open-market transaction the same day at $247.87 per share for gross proceeds of about $1,010,070. The filing also reports the related derivative conversion line (4,075 shares at $0.00), reflecting the option-to-share conversion.
Key Details
- Transaction date: February 27, 2026; Form 4 filed March 3, 2026 (within the typical 2-business-day reporting window).
- Exercise: 4,075 options exercised at $115.67 → total exercise cost ≈ $471,355.
- Sale: 4,075 shares sold on open market at $247.87 → gross proceeds ≈ $1,010,070.
- Derivative line: 4,075 shares reported as disposed at $0.00 consistent with option conversion reporting.
- Shares owned after transaction: Not specified in this Form 4.
- Footnotes of note:
- F1/F2: Some shares are held through the Johnson & Johnson Savings Plan / ESOP and include dividend reinvestment (as of 2/28/2026).
- F3: The options were awarded under the issuer’s Long‑Term Incentive Plan; such awards vest and become exercisable on the third anniversary of the grant date (background on the grant terms).
Context
- This was a same‑day exercise and sell (often called a cashless exercise): the insider exercised options and immediately sold the resulting shares, realizing the spread between the market price and the exercise price. Such transactions are common for option holders and do not by themselves indicate management’s long‑term view of the stock.
- This is an insider executive transaction (not a 10% owner disclosure). The filing is factual and does not state Decker’s remaining beneficial holdings.
Insider Transaction Report
Form 4
Decker Robert J
VP Corporate Controller
Transactions
- Exercise/Conversion
Common Stock
2026-02-27$115.67/sh+4,075$471,355→ 27,757 total - Sale
Common Stock
2026-02-27$247.87/sh−4,075$1,010,070→ 23,682 total - Exercise/Conversion
Employee Stock Options (Right to Buy)
[F3]2026-02-27−4,075→ 0 totalExercise: $115.67From: 2020-02-13Exp: 2027-02-13→ Common Stock (4,075 underlying)
Holdings
- 134(indirect: By ESOP)
Common Stock
[F1] - 646(indirect: By 401(k))
Common Stock
[F2]
Footnotes (3)
- [F1]Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (2/28/2026).
- [F2]Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (2/28/2026).
- [F3]Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Signature
/s/ Joleen Morgan, as attorney-in-fact for Robert J. Decker|2026-03-03